Nedosiran (sodium), CAS [[2247026-22-6]]

Produktübersicht

• Artikelname: Nedosiran (sodium), CAS [[2247026-22-6]]
• Artikelnummer: MCE-HY-132606A
• Hersteller Artikelnummer: HY-132606A
• Alternativnummer: MCE-HY-132606A-50MG, MCE-HY-132606A-100MG, MCE-HY-132606A-1MG, MCE-HY-132606A-5MG, MCE-HY-132606A-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: DCR-PHXC (sodium)

Produktbeschreibung

Nedosiran (DCR-PHXC) sodium is an RNA interference (RNAi) targeting lactate dehydrogenase (LDH). Nedosiran sodium represents an impactful potential therapeutic for primary hyperoxaluria (PH) with end-stage renal disease (ESRD). Nedosiran sodium is a GalNAc-dsRNA conjugate[1][2][3].

Produkteigenschaften

• Molekulargewicht: 20985.12
• Reinheit: 92.35
• CAS Nummer: [2247026-22-6]
• Formel: C662H865F19N231O413P57S6.xNa
• Target-Kategorie: Lactate Dehydrogenase,Small Interfering RNA (siRNA)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Oligonucleotides